|
A more recent version of this article appeared on June 1, 2006
Papers In Press, published online ahead of print March 13, 2006
J. Lipid Res., doi:10.1194/jlr.M500447-JLR200
Submitted on October 11, 2005
Revised on March 10, 2006
Accepted on March 12, 2006
Localization of StarD5 cholesterol binding protein
Daniel Rodriguez-Agudo, Shunlin Ren, Phillip B. Hylemon, Raul Montanez, Kaye Redford, Ramesh Natarajan, Miguel Angel Medina, Gregorio Gil, and William M. Pandak
Internal Medicine/Gastroenterology, Virginia Commonwealth University, Richmond, VA 23298-0341
Corresponding Author: William.Pandak{at}va.gov
Human StarD5 belongs to the StarD4 subfamily of START domain proteins. We previously reported that StarD5 is located in the cytosolic fraction of human liver and binds cholesterol and 25-hydroxycholesterol. After overexpression of the gene encoding StarD5 in primary rat hepatocytes, free cholesterol accumulated in intracellular membranes. These findings suggested StarD5 to be a directional cytosolic sterol transporter. The objective of the present study was to determine the localization of StarD5 in human liver. Western blot analysis confirmed StarD5s presence in the liver, but not in human hepatocytes. Immunohistochemistry studies showed StarD5 localized within sinusoidal lining cells in the human liver, and co-localized with CD68, a marker for Kupffer cells. Western-blot analyses identified the presence of StarD5 in monocytes, macrophages, as well as, mast cells, basophils, and promyelocytic cells, but not in human hepatocytes, endothelial cells, fibroblasts, osteocytes, astrocytes, or brain tissue. Cell fractionation and immunocytochemistry studies on THP-1 macrophages localized StarD5 to the cytosol, and supported an association with the Golgi. The presence of this cholesterol/25-hydroxycholesterol-binding protein in cells related to inflammatory processes provides new clues on the role of this protein in free-sterol transport in the cells and in lipid-mediated atherogenesis.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y.-C. Chen, R. K. Meier, S. Zheng, S. J. Khundmiri, M. T. Tseng, E. D. Lederer, P. N. Epstein, and B. J. Clark
Steroidogenic acute regulatory-related lipid transfer domain protein 5 localization and regulation in renal tubules
Am J Physiol Renal Physiol,
August 1, 2009;
297(2):
F380 - F388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Rodriguez-Agudo, S. Ren, E. Wong, D. Marques, K. Redford, G. Gil, P. Hylemon, and W. M. Pandak
Intracellular cholesterol transporter StarD4 binds free cholesterol and increases cholesteryl ester formation
J. Lipid Res.,
July 1, 2008;
49(7):
1409 - 1419.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. L. Miller
StAR Search--What We Know about How the Steroidogenic Acute Regulatory Protein Mediates Mitochondrial Cholesterol Import
Mol. Endocrinol.,
March 1, 2007;
21(3):
589 - 601.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.-J. Wang, J. M. Baez, R. Maurer, H. M. Dansky, and D. E. Cohen
Homozygous disruption of Pctp modulates atherosclerosis in apolipoprotein E-deficient mice
J. Lipid Res.,
November 1, 2006;
47(11):
2400 - 2407.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|